SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001370053-22-000040
Filing Date
2022-08-08
Accepted
2022-08-08 16:21:50
Documents
14
Period of Report
2022-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K anab-20220808.htm   iXBRL 8-K 32491
2 EX-99.1 q22022earningsrelease.htm EX-99.1 92185
  Complete submission text file 0001370053-22-000040.txt   312871

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20220808.xsd EX-101.SCH 2175
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20220808_def.xml EX-101.DEF 8981
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20220808_lab.xml EX-101.LAB 33134
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20220808_pre.xml EX-101.PRE 20654
8 EXTRACTED XBRL INSTANCE DOCUMENT anab-20220808_htm.xml XML 10999
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37985 | Film No.: 221144702
SIC: 2834 Pharmaceutical Preparations